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Conclusion: Demonstrating the association between the pres-
ence of oval cells and the progression of liver diseases could
provide an useful marker for understanding the correlation be-
tween the presence of oval cells and progression of disease and
creation of future treatment.
OL-006 Efﬁcacy, tolerability and safety of personalized
low-dose IFN treatment in patients with
HCV-related liver cirrhosis and severe
complications
Xiaoling Fan*, Wenyan Zhang, Yun-ru Li, Xiaojie Wang. Beijing
Ditan Hospital, Beijing, PR China
Object: To observe the efﬁcacy, tolerability and safety of per-
sonalized low-dose IFN treatment in patients with HCV-related
liver cirrhosis and severe complications.
Method: Personalized low-dose IFN treatment was performed in
61 patients. Less than 3 million units of personalized low-dose
natural IFN-alpha was administered QOD intramuscularly or less
than 50 μg Peg-IFN alpha-2b QW intrasubcutaneously, which de-
pended on patients tolerability, and plus Ribavirin 600 mg/day.
The course of treatment was at least 24 weeks. Some patients
received more than 2 years IFN maintenance therapy.
Results: Twenty of the 62 patients showed a rapid virological
response in 4 weeks treatment (32.25%). Twenty eight of 62
patients showed a complete early virological response in 12
weeks treatment (45.16%). Thirty four of 62 patients showed HCV
RNA undetectable in 24 weeks IFN therapy (54.83%). ALT levels
normalized (about 40 IU/L) at the end of 24 weeks therapy. 11
of 25 patients had a sustained virological response who were
given more than 2 years Maintenance Therapy (44%). Deﬁnitive
discontinuation of therapy was necessary in 7 patients (11.29 %)
because of side effects.
Conclusion: Personalized low-dose IFN and ribavirin combination
therapy was useful and safe in some patients with HCV-related
liver cirrhosis and severe complications for whom standard-dose
interferon and ribavirin combination therapy was difﬁcult.
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OL-007 Carbapenems resistance in Gram-negative bacilli
isolates in an intensive care unit
Eleni Antoniadou*,1, Spyridoula Vasiliagkou1, Nikolaos
Voloudakis 2, Savvato Tsingene3, Asimoula Koteli 3. 1Intensive
Care Unit, "G. Gennimatas" General Hospital of Thessaloniki;
2Medical School, University of Crete, Heraklion; 3Microbiology
Laboratory, “G. Gennimatas” General Hospital of Thessaloniki
Objective: to determine resistance of Ps. aeruginosa, A. bau-
mannii and K. pneumonniae as prevalent nosocomial agents to
commonly used antibiotics including imipenem, meropenem and
ertapenem.
Methods: Identiﬁcation of microorganisms and susceptibility test
was performed with the Vitek 2 (BioMerieux®, France) and the
susceptibility disc diffusion method according to CLSI directions.
For Klebsiella spp. extended-spectrum Beta-lactamases (ESBLs)
production was conﬁrmed by double-disc test. To screen for
metallo-b-lactamase production (MBL), a synergy test using an
imipenem and EDTA-containing discs was employed. Quality con-
trol was ensured by keeping weekly records of disk diffusion
Ps. aeruginosa (ATCC 27853). MIC values for carbapenems were
determined by the E-test (AB Biodisk, Solona, Sweden) as recom-
mended by manufacture. K. pneumoniae ATCC 70603 was used as
a positive ESBLs strain.
Results: Information was available on antibiotic suceptibility
of 1044 gram-negative bacteria, of which the most common
were A. baumanii 414, Ps. aeruginosa 328, K. pneumoniae 169.
No duplicate isolates from the same patients were included.
All microorganisms were isolated from tracheal tube aspirates,
urine, wound, blood and other sterile body ﬂuids. The resis-
tance rates (%) of A. baumanii, Ps. aeruginosa, and K. pneu-
moniae were: imipenem 76/61/67, meropenem 68/52/65, er-
tapenem 77/65/68, amikacin 88/48/40, piperacillin/tazobactam
82/35/67, ceftazidime 100/68/65, ciproﬂoxacin 92/64/15,
aztreonam 100/84/72. Of 169 isolates of K. pneumoniae 92
(54,43%) were ESBls.
Conclusions: The most isolates of A. baumannii were multi-drug
resistant. The majority of isolates were resistant to 5 or more
antibiotics tested and some strains were deﬁned by resistance
to all antimicrobial agents except colistin. The resistance to
carbapenems rose dramatically.
OL-008 Molecular characterization of extended-spectrum
β-lactamases and AmpC enzymes in
Enterobacteriaceae in Beijing, China
Lingxiang Zhu*,1,2, Di Jiang1,2, Zhiwei Zhang1,2, Can Wang1,2,
Jing Cheng1,2. 1National Engineering Research Center for
Beijing Biochip Technology; 2CapitalBio Corporation, PR China
Objectives: A study was conducted to evaluate the molecu-
lar characterization of extended-spectrum β-lactamases (ESBLs)
and plasmid-mediated AmpC enzymes in Enterobacteriaceae in
Beijing, China.
Methods: Production of ESBLs and plasmid-mediated AmpC
among 240 non-duplicate Enterobacteriaceae isolates was
screened by the phenotypic methods and the molecular methods.
The epidemiological relationship of the isolates was studied by
random ampliﬁed polymorphic DNA (RAPD) analysis.
Results: CTX-M type ESBLs were the most prevalent ESBLs. Three
E. coli isolates simultaneously harbored blaCTX-M-3 and blaCTX-M-9
genes. SHV-12 was the most prevalent SHV-type ESBL. SHV-2a,
SHV-2 and SHV-5 ESBLs, and SHV-27 and SHV-44 non-ESBLs were
detected. Two Klebsiella pneumoniae isolates expressed a novel
ESBL, SHV-43a, which had one substitution (Leu35Gln) compared
with SHV-43. DHA-1 was the most prevalent plasmid-mediated
AmpC enzyme, found mainly in K. pneumoniae (n=11). We also
identiﬁed the plasmid-mediated CMY-2 enzyme in two E. coli iso-
lates. RAPD analysis revealed that 53 CTX-M-13- and 7 CTX-M-3-
producing E. cloacae isolates recovered from a single hospital
exhibited a high similarity of RAPD patterns, indicating clone-
related spread.
Conclusions: This survey indicates the high frequencies of CTX-
M-9/3 ESBLs and plasmid-mediated DHA-1 in China, reports the
ﬁrst emergence of DHA-1-producing E. cloacae and interhospital
epidemic CTX-M-13/3-producing E. cloacae.
OL-009 Virulence factors determination and molecular
characterisation of Malaysian Vibrio cholerae
Cindy Shuan Ju Teh*, Kwai Lin Thong. Institute of Biological
Sciences, Faculty of Science, University of Malaya, Kuala
Lumpur, Malaysia
Objective: To determine the virulence proﬁles of Malaysian Vib-
rio cholerae and to investigate the relatedness of the strains
using molecular typing methods.
Methods: 43 V. cholerae were isolated from clinical and environ-
mental sources. Strains isolated were serogrouped and PCR were
carried out for determination of the virulence genes harbored in
each strain. The strains were further characterized using molec-
ular subtyping methods such as RAPD, ERIC, REP-PCR and PFGE
ﬁngerprinting to investigate the relatedness among the strains.
Results: Twenty-three O1, one O139 and 19 non-O1/nonO139
strains were isolated. All but one O1 strains harbored virulence
genes such as ctxA, zot, rtxA, rstR, toxT, toxR, tcpA, tcpI, and
